Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001649094-25-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-27 | PCVX | Cowan Elvia | SVP, Fin | A - Grant | $0.00 | +5,379 | 24.7K | +28% | $0 |
| DM | 2025-03-03 | 2025-02-28+ | PCVX | Cowan Elvia | SVP, Fin | F - Tax | $72.49 | -567 | 24.1K | -2% | -$41.1K |
| D | 2025-03-03 | 2025-02-27 | PCVX | Cowan Elvia | SVP, Fin | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | A | A | 5,379 | $0.00 | 24,673 | D | — | — | (F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| 2 | Common | Common Stock | 2025-02-28 | F | D | 242 | $73.02 | 24,431 | D | — | — | (F2) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 3 | Common | Common Stock | 2025-03-03 | F | D | 325 | $72.10 | 24,106 | D | — | — | (F2) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 4 | Derivative | Stock Option (right to buy) | 2025-02-27 | A | A | 17,961 | $0.00 | 17,961 | D | $74.22 · — to 2035-02-26 | 17,961 Common Stock | (F3) 1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |